BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8314721)

  • 21. Current treatment of Cutaneous T-Cell Lymphoma.
    Duvic M
    Dermatol Online J; 2001 Feb; 7(1):3. PubMed ID: 11328624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis.
    Kreuter A; Hoffmamm K; Altmeyer P
    J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental therapies in the treatment of cutaneous T-cell lymphoma.
    Foss FM; Kuzel TM
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1127-37. PubMed ID: 8522489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
    Dummer R; Foss F; Dreno B; Bagot M
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S26-32. PubMed ID: 16516673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bexarotene gel: a new skin-directed treatment option for cutaneous T-cell lymphomas.
    Martin AG
    J Drugs Dermatol; 2003 Apr; 2(2):155-67. PubMed ID: 12852367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management of cutaneous lymphoma ].
    Beylot-Barry M; Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H13-8. PubMed ID: 21703465
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous T-cell lymphoma: a review of current therapies and the future therapeutic implications of chemokine biology.
    Momtaz P; Zippin JH
    J Drugs Dermatol; 2009 Dec; 8(12):1142-9. PubMed ID: 20027945
    [No Abstract]   [Full Text] [Related]  

  • 28. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.
    Rook AH; Gottlieb SL; Wolfe JT; Vowels BR; Sood SS; Niu Z; Lessin SR; Fox FE
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():16-20. PubMed ID: 9020930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
    J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
    Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on treatment of cutaneous T-cell lymphoma.
    Gardner JM; Evans KG; Musiek A; Rook AH; Kim EJ
    Curr Opin Oncol; 2009 Mar; 21(2):131-7. PubMed ID: 19532014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
    Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous T cell lymphoma: update of treatment.
    Zackheim HS
    Dermatology; 1999; 199(2):102-5. PubMed ID: 10559573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous T-cell lymphoma: overview and nursing perspectives.
    McCann SA
    Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immuno-intervention in cutaneous lymphomas].
    Dummer R; Heinzerling L; Schmid MH; Burg G
    Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience.
    Heald PW; Perez MI; Christensen I; Dobbs N; McKiernan G; Edelson R
    Yale J Biol Med; 1989; 62(6):629-38. PubMed ID: 2534648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosage guidelines: extracorporeal photochemotherapy (photopheresis).
    Heald PW; Perez MI; Gasparro FP
    Arch Dermatol; 1990 Oct; 126(10):1369. PubMed ID: 2221948
    [No Abstract]   [Full Text] [Related]  

  • 39. Photopheresis for the treatment of cutaneous T cell lymphoma.
    Armus S; Keyes B; Cahill C; Berger C; Crater D; Scarborough D; Klainer A; Bisaccia E
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):898-902. PubMed ID: 2147701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's new in dermatology? Cutaneous lymphoma.
    Piette W
    Iowa Med; 1991 May; 81(5):204. PubMed ID: 1869424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.